Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul;16(7):61.
doi: 10.1007/s11910-016-0668-z.

Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis

Affiliations
Review

Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis

Rebecca L Hurst et al. Curr Neurol Neurosci Rep. 2016 Jul.

Abstract

Autoimmune myasthenia gravis (MG) is the prototypic, antibody-mediated neuromuscular disease and is characterized by a decrease in the number of functional acetylcholine receptors (AChR) within the muscle end plate zone of the neuromuscular junction (NMJ). Although the pathophysiology of AChR-mediated myasthenia gravis has been extensively studied over the last 40 years since its original description by Patrick and Lindstrom (Science 180:871-872, 1973), less is known about the much more recently described muscle-specific kinase (MuSK) antibody-mediated MG. MuSK-MG has features clinically distinct from Ach-R MG, as well as a different pattern of response to treatment and a unique immunopathogenesis.

Keywords: Acetylcholine receptor antibody; Muscle-specific receptor tyrosine kinase; Myasthenia gravis; Neuromuscular junction.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet Neurol. 2009 May;8(5):475-90 - PubMed
    1. Lancet Neurol. 2003 Feb;2(2):99-106 - PubMed
    1. Nat Med. 2001 Mar;7(3):365-8 - PubMed
    1. Neurology. 2005 Nov 8;65(9):1508-9 - PubMed
    1. Orphanet J Rare Dis. 2007 Nov 06;2:44 - PubMed

MeSH terms

LinkOut - more resources